Larry and Kitties
Member Since 2009
(December 9, 2022) – Today Elanco Animal Health (NYSE:ELAN) announced the U.S. Food and Drug Administration (FDA) approved Bexacat™ (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elanco’s innovative feline portfolio while addressing an unmet need for this chronic condition in adult cats.
https://www.elanco.com/en-us/news/elanco-announces-fda-approval-of-bexacat
Bexacat is anticipated to be available to U.S. veterinarians in the first quarter of 2023.
https://www.elanco.com/en-us/news/elanco-announces-fda-approval-of-bexacat
Bexacat is anticipated to be available to U.S. veterinarians in the first quarter of 2023.